학술논문
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
Document Type
Article
Author
Martín, Miguel; Zielinski, Christoph; Ruiz-Borrego, Manuel; Carrasco, Eva; Ciruelos, Eva M.; Muñoz, Montserrat; Bermejo, Begoña; Margelí, Mireia; Csöszi, Tibor; Antón, Antonio; Turner, Nicholas; Casas, María I.; Morales, Serafín; Alba, Emilio; Calvo, Lourdes; de la Haba-Rodríguez, Juan; Ramos, Manuel; Murillo, Laura; Santaballa, Ana; Alonso-Romero, José L.; Sánchez-Rovira, Pedro; Corsaro, Massimo; Huang, Xin; Thallinger, Christiane; Kahan, Zsuzsanna; Gil-Gil, Miguel
Source
In European Journal of Cancer June 2022 168:12-24
Subject
Language
ISSN
0959-8049